These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 24340948)

  • 1. [The first experience of application of standardized genotype technique of identification of HIV-tropism].
    Lopatukhin AÉ; Kireev DE; Poliakov AN; Bukin EK; Kaiser R; Luebke N; Kuevda DA; Shipulin GA
    Klin Lab Diagn; 2013 Jun; (6):46-8. PubMed ID: 24340948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of C-C chemokine receptor type 5 tropism among human immunodeficiency virus 1-infected patients in South Korea.
    Song JE; Ahn MY; Kim WJ; Kim SW; Lee JS; Ku NS; Kim JH; Kim KH; Ann H; Choi JY
    J Med Virol; 2018 Nov; 90(11):1720-1723. PubMed ID: 29981165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shift of HIV tropism in stem-cell transplantation with CCR5 Delta32 mutation.
    Kordelas L; Verheyen J; Beelen DW; Horn PA; Heinold A; Kaiser R; Trenschel R; Schadendorf D; Dittmer U; Esser S;
    N Engl J Med; 2014 Aug; 371(9):880-2. PubMed ID: 25162903
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of chemokine receptor gene variants with HIV-1 genotype predicted tropism.
    Parczewski M; Urbańska A; Maciejewska K; Clark J; Leszczyszyn-Pynka M
    HIV Med; 2014 Nov; 15(10):577-86. PubMed ID: 24750723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group.
    Svicher V; D'Arrigo R; Alteri C; Andreoni M; Angarano G; Antinori A; Antonelli G; Bagnarelli P; Baldanti F; Bertoli A; Borderi M; Boeri E; Bonn I; Bruzzone B; Callegaro AP; Cammarota R; Canducci F; Ceccherini-Silberstein F; Clementi M; Monforte AD; De Luca A; Di Biagio A; Di Gianbenedetto S; Di Perri G; Di Pietro M; Fabeni L; Fadda G; Galli M; Gennari W; Ghisetti V; Giacometti A; Gori A; Leoncini F; Maggiolo F; Maserati R; Mazzotta F; Micheli V; Meini G; Monno L; Mussini C; Nozza S; Paolucci S; Parisi S; Pecorari M; Pizzi D; Quirino T; Re MC; Rizzardini G; Santangelo R; Soria A; Stazi F; Sterrantino G; Turriziani O; Viscoli C; Vullo V; Lazzarin A; Perno CF;
    New Microbiol; 2010 Jul; 33(3):195-206. PubMed ID: 20954437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of CXCR4-using HIV-1 in patients with recently diagnosed infection: correlates and evidence for transmission.
    Chalmet K; Dauwe K; Foquet L; Baatz F; Seguin-Devaux C; Van Der Gucht B; Vogelaers D; Vandekerckhove L; Plum J; Verhofstede C
    J Infect Dis; 2012 Jan; 205(2):174-84. PubMed ID: 22147802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two genotypic algorithms to determine HIV-1 tropism.
    Soulié C; Derache A; Aimé C; Marcelin AG; Carcelain G; Simon A; Katlama C; Calvez V
    HIV Med; 2008 Jan; 9(1):1-5. PubMed ID: 18199166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of genotypic tropism testing in clinical practice.
    Wyatt H; Herman OM; Macartney M; Conibear T; Garcia-Diaz A; Booth C; McCormick A; Smith C; Johnson MA; Irish D; Webster DP
    Int J STD AIDS; 2015 Jul; 26(8):593-4. PubMed ID: 25147237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission of the X4 phenotype of HIV-1: is there evidence against the "random transmission" hypothesis?
    Hedskog C; Mild M; Albert J
    J Infect Dis; 2012 Jan; 205(2):163-5. PubMed ID: 22147793
    [No Abstract]   [Full Text] [Related]  

  • 10. Evolution of coreceptor utilization to escape CCR5 antagonist therapy.
    Zhang J; Gao X; Martin J; Rosa B; Chen Z; Mitreva M; Henrich T; Kuritzkes D; Ratner L
    Virology; 2016 Jul; 494():198-214. PubMed ID: 27128349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based V3 genotypic tropism assay: a retrospective analysis using screening samples from the A4001029 and MOTIVATE studies.
    McGovern RA; Thielen A; Mo T; Dong W; Woods CK; Chapman D; Lewis M; James I; Heera J; Valdez H; Harrigan PR
    AIDS; 2010 Oct; 24(16):2517-25. PubMed ID: 20736814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low frequency of HIV-1 tropism evolution in patients successfully treated for at least 2 years.
    Soulie C; Lambert-Niclot S; Wirden M; Simon A; Valantin MA; Fourati S; Tubiana R; Katlama C; Calvez V; Marcelin AG
    AIDS; 2011 Feb; 25(4):537-9. PubMed ID: 21139487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved V3 genotyping with duplicate PCR amplification for determining HIV-1 tropism.
    Raymond S; Recordon-Pinson P; Saliou A; Delobel P; Nicot F; Descamps D; Marcelin AG; Flandre P; Calvez V; Masquelier B; Izopet J;
    J Antimicrob Chemother; 2011 Sep; 66(9):1972-5. PubMed ID: 21676905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concordance between HIV-2 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA.
    Visseaux B; Charpentier C; Taieb A; Damond F; Bénard A; Larrouy L; Chêne G; Brun-Vézinet F; Matheron S; Descamps D;
    AIDS; 2013 Jan; 27(2):292-5. PubMed ID: 23095312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep-Sequencing Analysis of the Dynamics of HIV-1 Quasiespecies in Naive Patients during a Short Exposure to Maraviroc.
    Cascajero A; Rastrojo A; Díez-Fuertes F; Hernández-Novoa B; Aguado B; Moreno S; Alcami J; Pérez-Olmeda M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV co-receptor tropism prediction remains stable over time in treatment-naïve patients.
    Philip KE; Macartney MJ; Conibear TC; Smith CJ; Marshall N; Johnson MA; Haque T; Webster DP
    Int J STD AIDS; 2016 Jun; 27(7):576-80. PubMed ID: 25999168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pace of Coreceptor Tropism Switch in HIV-1-Infected Individuals after Recent Infection.
    Arif MS; Hunter J; Léda AR; Zukurov JPL; Samer S; Camargo M; Galinskas J; Kallás EG; Komninakis SV; Janini LM; Sucupira MC; Diaz RS
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28659473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on clinical and methodological recommendations for genotypic determination of HIV tropism to guide the usage of CCR5 antagonists.
    Poveda E; Paredes R; Moreno S; Alcamí J; Córdoba J; Delgado R; Gutiérrez F; Llibre JM; García Deltoro M; Hernández-Quero J; Pulido F; Iribarren JA; García F
    AIDS Rev; 2012; 14(3):208-17. PubMed ID: 22833064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monophylogenetic HIV-1C epidemic in Ethiopia is dominated by CCR5-tropic viruses-an analysis of a prospective country-wide cohort.
    Kalu AW; Telele NF; Gebreselasie S; Fekade D; Abdurahman S; Marrone G; Sönnerborg A
    BMC Infect Dis; 2017 Jan; 17(1):37. PubMed ID: 28061826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of triplicate testing on HIV genotypic tropism prediction in routine clinical practice.
    Symons J; Vandekerckhove L; Paredes R; Verhofstede C; Bellido R; Demecheleer E; van Ham PM; van Lelyveld SF; Stam AJ; van Versendaal D; Nijhuis M; Wensing AM
    Clin Microbiol Infect; 2012 Jun; 18(6):606-12. PubMed ID: 21906210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.